Pavmed Series Z Stock Price on May 28, 2024
| PAVMZ Stock | USD 0.02 0.0001 0.67% |
Below is the normalized historical share price chart for PAVmed Series Z extending back to April 10, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of PAVmed Series stands at 0.02, as last reported on the 30th of November, with the highest price reaching 0.02 and the lowest price hitting 0.02 during the day.
If you're considering investing in PAVmed Stock, it is important to understand the factors that can impact its price. PAVmed Series is out of control given 3 months investment horizon. PAVmed Series Z maintains Sharpe Ratio (i.e., Efficiency) of 0.25, which implies the company had a 0.25% return per unit of standard deviation over the last 3 months. We have collected data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 17.75% are justified by taking the suggested risk. Use PAVmed Series Mean Deviation of 36.9, coefficient of variation of 472.84, and Market Risk Adjusted Performance of 1.04 to evaluate company specific risk that cannot be diversified away.
At this time, PAVmed Series' Other Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 7.6 M in 2024, despite the fact that Total Stockholder Equity is likely to grow to (51.1 M). . Price Earnings To Growth Ratio is likely to rise to 0.01 in 2024, whereas Price To Sales Ratio is likely to drop 11.54 in 2024. PAVmed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of April 2018 | Beta 0.693 |
PAVmed |
Sharpe Ratio = 0.2547
| Best Portfolio | Best Equity | PAVMZ | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 69.67 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.25 actual daily | 20 80% of assets perform better |
Based on monthly moving average PAVmed Series is performing at about 20% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PAVmed Series by adding it to a well-diversified portfolio.
Book Value (6.62) | Shares Float 8.9 M | Shares Short Prior Month 46 K | Shares Short 76.8 K | Revenue Per Share 0.459 |
PAVmed Series Valuation on May 28, 2024
It is possible to determine the worth of PAVmed Series on a given historical date. On May 28, 2024 PAVmed was worth 0.0299 at the beginning of the trading date compared to the closed value of 0.0301. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of PAVmed Series stock. Still, in general, we apply an absolute valuation method to find PAVmed Series' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of PAVmed Series where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against PAVmed Series' related companies.
| Open | High | Low | Close | Volume | |
| 0.06 | 0.06 | 0.02 | 0.02 | 96,630 | |
05/28/2024 | 0.03 | 0.05 | 0.03 | 0.03 | 5,329 |
| 0.03 | 0.03 | 0.03 | 0.03 | 3,697 |
| Backtest PAVmed Series | | | PAVmed Series History | | | PAVmed Series Valuation | Previous | Next |
PAVmed Series Trading Date Momentum on May 28, 2024
| On May 29 2024 PAVmed Series Z was traded for 0.03 at the closing time. The highest daily price throughout the period was 0.03 and the lowest price was 0.03 . The daily volume was 3.7 K. The net trading volume on 05/29/2024 added to the next day price jump. The trading delta at closing time to closing price of the next trading day was 2.99% . The trading delta at closing time to current closing price is 0.33% . |
PAVmed Series Z Fundamentals Correlations and Trends
By evaluating PAVmed Series' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among PAVmed Series' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. PAVmed financial account trend analysis is a perfect complement when working with valuation or volatility modules.About PAVmed Series Stock history
PAVmed Series investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for PAVmed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in PAVmed Series Z will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing PAVmed Series stock prices may prove useful in developing a viable investing in PAVmed Series
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 7.2 M | 7.6 M | |
| Net Loss | -31.1 M | -29.6 M |
PAVmed Series Stock Technical Analysis
PAVmed Series technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
PAVmed Series Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
PAVmed Series Z cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
PAVmed Series November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how PAVmed Series stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PAVmed Series shares will generate the highest return on investment. By undertsting and applying PAVmed Series stock market strength indicators, traders can identify PAVmed Series Z entry and exit signals to maximize returns
PAVmed Series Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for PAVmed Series' price direction in advance. Along with the technical and fundamental analysis of PAVmed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of PAVmed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1715 | |||
| Jensen Alpha | 9.8 | |||
| Total Risk Alpha | 2.35 | |||
| Sortino Ratio | 0.2497 | |||
| Treynor Ratio | 1.03 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for PAVmed Stock Analysis
When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.